Evidence map›Paper›PMID 30242229›Full record

ReviewMolecular psychiatry2019

Memory and cognition in schizophrenia.

J Y Guo, J D Ragland, C S Carter

Abstract readReview
In one paragraph

Review in Molecular psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A Systematic Review of the Current Measures of Theory of Mind in Adults with Schizophrenia.International journal of environmental research and public health · 2021
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Methylglyoxal Affects Dopamine Homeostasis in SH-SY5Y Cells Through the Modulation of miR-190a and miR-214.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  16. A J-domain protein enhances memory by promoting physiological amyloid formation inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  17. Article
  18. Article
  19. Deletion ofFrontiers in cellular neuroscience · 2026
    Article
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J Y GuoDepartment of Psychiatry and Behavioral Sciences, Imaging Research Center, University of California at Davis, Sacramento, CA, USA. joyce.yu.guo@gmail.com.
J D RaglandDepartment of Psychiatry and Behavioral Sciences, Imaging Research Center, University of California at Davis, Sacramento, CA, USA.
C S CarterDepartment of Psychiatry and Behavioral Sciences, Imaging Research Center, University of California at Davis, Sacramento, CA, USA. cscarter@ucdavis.edu.

Funding

2/5-Cognitive Neuroscience Task Reliability & Clinical Applications ConsortiumR01MH084826 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI CARTER, CAMERON S. · 2008 to 2023
$4.0M
Reducing Duration of Untreated Psychosis through Rapid Identification and EngagementR01MH104235 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARTER, CAMERON S. · 2014 to 2017
$3.8M
Neural Mechanisms of Memory Dysfunction in SchizophreniaR01MH105411 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAGLAND, JOHN D, RANGANATH, CHARAN · 2015 to 2018
$1.9M
NIMH NIH HHS R01 MH084826NIMH NIH HHS R01 MH104235NIMH NIH HHS R01 MH105411U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH105411U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) RO1MH084826
6 · The paper itself

Abstract

Episodic memory deficits are consistently documented as a core aspect of cognitive dysfunction in schizophrenia patients, present from the onset of the illness and strongly associated with functional disability. Over the past decade, research using approaches from experimental cognitive neuroscience revealed disproportionate episodic memory impairments in schizophrenia (Sz) under high cognitive demand relational encoding conditions and relatively unimpaired performance under item-specific encoding conditions. These specific deficits in component processes of episodic memory reflect impaired activation and connectivity within specific elements of frontal-medial temporal lobe circuits, with a central role for the dorsolateral prefrontal cortex (DLPFC), relatively intact function of ventrolateral prefrontal cortex and variable results in the hippocampus. We propose that memory deficits can be understood within the broader context of cognitive deficits in Sz, where impaired DLPFC-related cognitive control has a broad impact across multiple cognitive domains. The therapeutic implications of these findings are discussed.

Indexed as

AdultBrain MappingCognitionCognition DisordersCognitive DysfunctionFemaleHumansMagnetic Resonance ImagingMaleMemoryMemory DisordersMemory, EpisodicMemory, Short-TermMiddle AgedNeuropsychological TestsPrefrontal Cortex

Identifiers

PMID30242229
PMCPMC6428626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.